Citation

Scott JS, Degorce SL, Anjum R, Culshaw J, Davies RDM, Davies NL, Dillman KS, Dowling JE, Drew L, Ferguson AD, Groombridge SD, Halsall CT, Hudson JA, Lamont S, Lindsay NA, Marden SK, Mayo MF, Pease JE, Perkins DR, Pink JH, Robb GR, Rosen A, Shen M, McWhirter C, Wu D.: Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88L265P Diffuse Large B-Cell Lymphoma. J Med Chem, Volume 60 (24), 2017

Authors

Anjum R, Culshaw J, Davies NL, Davies RDM, Degorce SL, Dillman KS, Dowling JE, Drew L, Ferguson AD, Groombridge SD, Halsall CT, Hudson JA, Lamont S, Lindsay NA, Marden SK, Mayo MF, McWhirter C, Pease JE, Perkins DR, Pink JH, Robb GR, Rosen A, Scott JS, Shen M, Wu D.

Journal

J Med Chem

Year

2017

DOI

10.1021/acs.jmedchem.7b01290

PubMed

29172502

Machine-readable

REST APIRDF